2017
DOI: 10.1111/febs.14098
|View full text |Cite
|
Sign up to set email alerts
|

N‐glycosylation of the β2 adrenergic receptor regulates receptor function by modulating dimerization

Abstract: Peptide-N-glycosidase F (PNGase F, EC 3.2.2.11); endo-β-N-acetylglucosaminidase A (Endo-A, EC 3.2.1.96).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 49 publications
(74 reference statements)
0
11
0
Order By: Relevance
“…Although the reason for this loss of beta adrenergic receptor activity is not fully understood, differences observed in the expression of β1and β3-AR may provide at least a partial explanation. In addition, our pharmacological data showed that β3AR was almost entirely glycosylated in M+T1AM cells, suggesting that β3-AR might be desensitized, as this post-translational modification has been known to play an important role in receptor function [26] and indicated, for the first time, the potentiality of T1AM to affect protein function by promoting post-translational modifications. This finding indicated that T1AM treatment might lead to constitutive activation of β3AR, leading to desensitization of this receptor.…”
Section: Discussionmentioning
confidence: 68%
“…Although the reason for this loss of beta adrenergic receptor activity is not fully understood, differences observed in the expression of β1and β3-AR may provide at least a partial explanation. In addition, our pharmacological data showed that β3AR was almost entirely glycosylated in M+T1AM cells, suggesting that β3-AR might be desensitized, as this post-translational modification has been known to play an important role in receptor function [26] and indicated, for the first time, the potentiality of T1AM to affect protein function by promoting post-translational modifications. This finding indicated that T1AM treatment might lead to constitutive activation of β3AR, leading to desensitization of this receptor.…”
Section: Discussionmentioning
confidence: 68%
“…Previous studies have shown that β2‐adrenergic receptor can form SDS‐resistant (Hebert et al., 1996) and SDS‐sensitive homodimers (Angers et al., 2000). Recently, N‐linked glycosylation of the extracellular N‐terminal domain has been found to be involved in receptor dimerization of the human bradykinin B2 (Michineau et al., 2006) and β2‐adrenergic receptors (Li et al., 2017). In this study, in SDS‐PAGE experiments with anti‐Flag antibody, two bands, 45 and 85 kDa corresponding to di‐ and mono‐species, were detected in both HEK‐293T and DU145 cells.…”
Section: Discussionmentioning
confidence: 99%
“…Since N-linked glycosylation is a critical step in the maturation of RTKs, its disruption has been proposed to be an effective strategy to target both primary and redundant RTK signaling 24,28 . However, normal cells may also rely on this pathway for their growth and development 29,30 . Nevertheless, suppression of GluIIβ may represent a novel approach to selectively inhibit N-linked glycosylation and thus specifically reduce RTKs activities in tumor cells.…”
Section: Discussionmentioning
confidence: 99%